Filing Details

Accession Number:
0001179110-15-012247
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-17 19:21:34
Reporting Period:
2015-08-13
Filing Date:
2015-08-17
Accepted Time:
2015-08-17 19:21:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1607737 D Renee Gala C/o Theravance Biopharma Us, Inc.
901 Gateway Blvd
South San Francisco CA 94080
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-08-13 5,000 $12.19 154,279 No 4 P Direct
Ordinary Shares Acquisiton 2015-08-17 5,000 $12.16 161,177 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price per share for the open market purchase on August 13, 2015. The shares were purchased at prices ranging from $12.18 to $12.20 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  2. Represents the weighted average purchase price per share for the open market purchase on August 17, 2015. The shares were purchased at prices ranging from $12.12 to $12.24 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. Includes 1,898 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2015.